These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17519901

  • 1. Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts.
    Liu J, Harada H, Ogura M, Shibata T, Hiraoka M.
    Br J Cancer; 2007 Jun 18; 96(12):1871-8. PubMed ID: 17519901
    [Abstract] [Full Text] [Related]

  • 2. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
    Kaliberov SA, Market JM, Gillespie GY, Krendelchtchikova V, Della Manna D, Sellers JC, Kaliberova LN, Black ME, Buchsbaum DJ.
    Gene Ther; 2007 Jul 18; 14(14):1111-9. PubMed ID: 17495948
    [Abstract] [Full Text] [Related]

  • 3. Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene.
    Kaliberova LN, Della Manna DL, Krendelchtchikova V, Black ME, Buchsbaum DJ, Kaliberov SA.
    Mol Cancer Ther; 2008 Sep 18; 7(9):2845-54. PubMed ID: 18790765
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer.
    Deng LY, Wang JP, Gui ZF, Shen LZ.
    World J Gastroenterol; 2011 Jun 28; 17(24):2958-64. PubMed ID: 21734808
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H, Zhang L, Tang Y, Deisseroth A.
    Cancer Gene Ther; 2003 May 28; 10(5):388-95. PubMed ID: 12719708
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
    Marignol L, Foley R, Southgate TD, Coffey M, Hollywood D, Lawler M.
    J Gene Med; 2009 Feb 28; 11(2):169-79. PubMed ID: 19051213
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models.
    Stackhouse MA, Pederson LC, Grizzle WE, Curiel DT, Gebert J, Haack K, Vickers SM, Mayo MS, Buchsbaum DJ.
    Gene Ther; 2000 Jun 28; 7(12):1019-26. PubMed ID: 10871750
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
    Hanna NN, Mauceri HJ, Wayne JD, Hallahan DE, Kufe DW, Weichselbaum RR.
    Cancer Res; 1997 Oct 01; 57(19):4205-9. PubMed ID: 9331076
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J, Wei F, Wang H, Li H, Qiu W, Ren P, Chen X, Huang Q.
    Cancer Biother Radiopharm; 2010 Aug 01; 25(4):487-95. PubMed ID: 20735209
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.